The content of this article is more than 5 years old. Please be aware that information provided may no longer be accurate, up-to-date, or relevant.
Alta Charo was named to the advisory group that will be steering the National Academy of Sciences and National Academy of Medicine in its new initiative on human gene editing. The initiative guides decision-making related to technologies that may lead to new treatments for diseases but could also in theory be used to alter the human germline.
Submitted by Law School News on June 15, 2015
This article appears in the categories: Activities & Scholarship
